HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang-Jie Cai Selected Research

Pathologic Constriction (Stenosis)

7/2010[Risk factors predicting late mortality after liver transplantation for benign end-stage liver disease].
6/2010Contrast-enhanced ultrasound for the evaluation of hepatic artery stenosis after liver transplantation: potential role in changing the clinical algorithm.
11/2006[The practical value of endoscopic retrograde cholangiography in biliary complications after liver transplantation].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang-Jie Cai Research Topics

Disease

5Critical Illness (Critically Ill)
01/2023 - 04/2020
5Hepatocellular Carcinoma (Hepatoma)
01/2016 - 09/2004
5End Stage Liver Disease
12/2011 - 12/2008
4Infections
01/2022 - 10/2009
4Neoplasms (Cancer)
06/2009 - 09/2004
3Liver Diseases (Liver Disease)
01/2022 - 12/2011
3Pathologic Constriction (Stenosis)
07/2010 - 11/2006
1Body Weight (Weight, Body)
01/2023
1Candidiasis (Moniliasis)
01/2023
1Invasive Fungal Infections
01/2022
1Brain Death (Brain Dead)
10/2014
1Edema (Dropsy)
10/2014
1Necrosis
10/2014
1Hepatitis
01/2010
1Leukemia
10/2009
1Hepatopulmonary Syndrome
06/2009
1Intestinal Obstruction (Obstruction, Intestinal)
07/2008
1Residual Neoplasm
04/2007
1Carcinoma (Carcinomatosis)
11/2006
1Chronic Hepatitis B
08/2005
1Hepatitis B
08/2005

Drug/Important Bio-Agent (IBA)

4Voriconazole (Vfend)FDA LinkGeneric
01/2023 - 04/2020
2ABO Blood-Group SystemIBA
12/2011 - 07/2010
2Immunosuppressive Agents (Immunosuppressants)IBA
10/2009 - 04/2007
2Sirolimus (Rapamycin)FDA Link
04/2007 - 12/2006
2Caspase 3 (Caspase-3)IBA
04/2007 - 12/2006
1Polymyxin B (Aerosporin)FDA LinkGeneric
01/2023
1Antifungal AgentsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2016
1GlycogenIBA
10/2014
1dicarboxydine (DCD)IBA
10/2014
1Toll-Like Receptor 2IBA
06/2009
1N 30IBA
06/2009
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2009
1Toll-Like Receptors (Toll-Like Receptor)IBA
06/2009
1LipopolysaccharidesIBA
06/2009
1AntigensIBA
06/2009
1VancomycinFDA LinkGeneric
07/2008
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
07/2008
1Apoptosis Regulatory ProteinsIBA
04/2007
1Bisbenzimidazole (Hoechst 33258)IBA
04/2007
1Indicators and Reagents (Reagents)IBA
04/2007
1oridoninIBA
11/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2005
1Adenosine Triphosphate (ATP)IBA
09/2004

Therapy/Procedure

10Liver Transplantation
12/2011 - 09/2004
4Therapeutics
01/2023 - 11/2006
2Drug Therapy (Chemotherapy)
10/2009 - 09/2004
1Continuous Renal Replacement Therapy
01/2023
1Extracorporeal Membrane Oxygenation
07/2022
1Transplantation
01/2010
1Artificial Liver (Bioartificial Liver)
01/2010